The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

OPGAN     (2S)-N-[[(1S)-4- (diaminomethylideneamino)...

Synonyms: SureCN6171515, AC1L3TLV, AR-1G9317, S-2444, AC1Q5OJ9, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Chromogenic substrate S-2444

 

High impact information on Chromogenic substrate S-2444

  • Similar inhibitory effects of hCG on urokinase-plasminogen activator (uPA) and the activity of trophoblast-conditioned media were shown (measured by degradation of S-2444) [2].
  • The active 2-chain uPA generated from scuPA by PSA was measured by hydrolyzation of S-2444, a synthetic substrate for uPA [3].
  • No difference was found, however, among recombinant and natural scu-PAs in the kinetics of conversion into two-chain active forms (tcu-PAs) by human plasmin, and in the KM and kcat values of tcu-PA activity on the chromogenic substrate S-2444 and on human plasminogen [4].
  • Suppression of matrix metalloproteinase activity by SI-27: detection by a new activity assay with S-2444, a specific chromogenic peptide [5].
  • However, the plasminogen activator cleaved S-2288 to a greater extent than S-2444 in contrast to urokinase [6].
 

Biological context of Chromogenic substrate S-2444

 

Anatomical context of Chromogenic substrate S-2444

  • Single-chain urokinase-like plasminogen activators have been determined by an indirect method (after activation to urokinase by plasmin and chromogenic assay with S 2444) in the cytosol of a rat tumor model [9].
 

Associations of Chromogenic substrate S-2444 with other chemical compounds

 

Gene context of Chromogenic substrate S-2444

  • Surprisingly, the isolated PCI inhibited the amidolytic activity of urokinase (u-PA) on Glu-Gly-Arg-pNA (S-2444) in a time-dependent manner [11].
 

Analytical, diagnostic and therapeutic context of Chromogenic substrate S-2444

References

  1. Urokinase-type plasminogen activator in ascites obtained from the patient with mammary cancer. Hayashi, S., Yamada, K. Thromb. Res. (1985) [Pubmed]
  2. High levels of human chorionic gonadotropin retard first trimester trophoblast invasion in vitro by decreasing urokinase plasminogen activator and collagenase activities. Yagel, S., Geva, T.E., Solomon, H., Shimonovitz, S., Reich, R., Finci-Yeheskel, Z., Mayer, M., Milwidsky, A. J. Clin. Endocrinol. Metab. (1993) [Pubmed]
  3. Prostate-specific antigen activates single-chain urokinase-type plasminogen activator. Yoshida, E., Ohmura, S., Sugiki, M., Maruyama, M., Mihara, H. Int. J. Cancer (1995) [Pubmed]
  4. The differential glycosylation of human pro-urokinase from various recombinant mammalian cell lines does not affect activity and binding to PAI-1. Sarubbi, E., Nolli, M.L., Robbiati, F., Soffientini, A., Parenti, F., Cassani, G. Thromb. Haemost. (1989) [Pubmed]
  5. Suppression of matrix metalloproteinase activity by SI-27: detection by a new activity assay with S-2444, a specific chromogenic peptide. Yoshida, D., Watanabe, K., Noha, M., Takahashi, H., Teramoto, A. J. Neurooncol. (2002) [Pubmed]
  6. Plasminogen activator in bronchoalveolar fluid. Matsuo, O., Sakai, T., Bando, H., Okada, K., Nakajima, S., Takagi, O., Izaki, S. Haemostasis (1986) [Pubmed]
  7. Human follicular fluid protease and antiprotease activities: a suggested correlation with ability of oocytes to undergo in vitro fertilization. Milwidsky, A., Kaneti, H., Finci, Z., Laufer, N., Tsafriri, A., Mayer, M. Fertil. Steril. (1989) [Pubmed]
  8. Properties of the clotting enzyme responsible for endotoxin-mediated Limulus coagulation. Torano, A.E., Nakamura, S., Levin, J. Thromb. Res. (1984) [Pubmed]
  9. Single-chain, urokinase-type plasminogen activator in a tumor model linked to metastatic potential. Kellen, J.A., Mirakian, A., Wong, A. In Vivo (1988) [Pubmed]
  10. A plasminogen activator from benign ovarian cystadenoma: partial purification and characterization. Cheung, A., Lau, H.K., Yuen, P. Thromb. Res. (1986) [Pubmed]
  11. Inhibition of urokinase by protein C-inhibitor (PCI). Evidence for identity of PCI and plasminogen activator inhibitor 3. Stief, T.W., Radtke, K.P., Heimburger, N. Biol. Chem. Hoppe-Seyler (1987) [Pubmed]
  12. Down-regulation of urokinase secretion from a human lymphoma cell line RC-K8 by dexamethasone without inducing plasminogen activator inhibitors. Niiya, K., Nsimba, M., Hayashi, T., Sakuragawa, N. Thromb. Res. (1992) [Pubmed]
  13. Spectrometric determination of urokinase in urine after gel filtration, using the chromogenic substrate S-2444. Paar, D., Maruhn, D. J. Clin. Chem. Clin. Biochem. (1980) [Pubmed]
  14. Effects of wine on plasma fibrinolytic and coagulation systems. Sumi, H., Kozaki, Y., Yatagai, C., Hamada, H. Nihon Arukōru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence. (1998) [Pubmed]
  15. Gene amplification and high-level expression of human pro-urokinase cDNA in Chinese hamster ovary cells. Zhang, H.Q., Li, F.Z., Yu, W.Y., Li, X.Z., Fang, J.M., Fei, E.G., Huang, C.F. Sci. China, Ser. B, Chem. Life Sci. Earth Sci. (1994) [Pubmed]
 
WikiGenes - Universities